NoNeckTech

A 68-year-old Florida man dressed as Santa Claus was arrested in a child predator sting after allegedly attempting to meet a 13-year-old undercover detective and offering money for sex, authorities said.

Bunk vials.? I’m pretty skeptical. I put my name on this company and stand behind everything I sell… for good fucking reason. You need to trust not only the company but the people that are behind it. I’d suggest you tell your buddy to reach out directly… Or shit, make it public. We can talk about it here in front of everyone. I’m positive there’s something that doesn’t add up here. I personally think you a full of shit but let’s see.

Real shit

If you’re taking Retatrutide or considering it be aware of potential side effects. Here’s what we know based off what clinical trials actually show: Most Common Side Effects (GI-related *the big ones*) - Nausea: Up to 38–43% at higher doses (9–12 mg) vs 11% on placebo, roughly 2 out of every 5 people. Most common during dose escalation and usually mild-to-moderate. - Diarrhea: 33–35% at higher doses vs 13% placebo, about 1 in 3 people. - Vomiting: 20–21% at higher doses vs 0–2% placebo, roughly 1 in 5 people. - Constipation: 22–25% at higher doses vs 9% placebo, about 1 in 4–5 people. These GI effects are dose-dependent, happen most during ramp-up, and often ease over time. Slower titration helps. Other Notable Side Effects Include: - Dysesthesia (abnormal skin sensations, tingling, sensitivity, tenderness): 8.8–20.9% at higher doses vs 0.7% placebo, as high as 1 in 5 people on 12 mg. Generally mild and rarely caused discontinuation. - Increased heart rate: Dose-dependent and transient (peaks around 4–7 bpm at higher doses, then often declines). Not a “% of people” issue but a common class effect. - Decreased appetite (beyond the intended effect): 18–19% at high doses. Less Common / Serious Stuff - Overall adverse events: 73–94% of people on retatrutide (vs 70% on placebo) but most are mild GI stuff. - Discontinuation due to side effects: 6–18% depending on dose and trial (vs 0–4% placebo) roughly 1 in 6 to 1 in 16 people stop because of tolerability. - Serious adverse events: 4% (about 1 in 25 people) same rate as placebo. No new red flags in the data so far. - Transient liver enzyme (ALT) rise >3x normal: 1% (1 in 100 people); no hepatotoxicity signals. - Pancreatitis, gallbladder issues, hypersensitivity: Rare and similar to or only slightly higher than other GLP-1 drugs (generally <1–2%, or fewer than 1 in 50–100). No pancreatitis signals above background in most analyses. Retatrutide’s side-effect profile is very similar to other incretin drugs (semaglutide/tirzepatide) but can feel a bit more intense at the highest doses because of the added glucagon effect. Most issues are manageable, happen early, and improve. However, individual responses vary wildly.

why is no energy drink company making uncaffienated drinks??? i wanna drink 10 alani's a day without dying.

More than 300,000 people stood outside for hours to listen to some dude in a suit read names off an index card. The European mind simply cannot comprehend this.